Structural studies of antibiotics not only provide a shortcut to medicine allowing for rational structure-based drug design, but may also capture snapshots of dynamic intermediates that become 'frozen' after inhibitor binding 1, 2 . Myxopyronin inhibits bacterial RNA polymerase (RNAP) by an unknown mechanism 3 . Here we report the structure of dMyx-a desmethyl derivative of myxopyronin B 4 -complexed with a Thermus thermophilus RNAP holoenzyme. The antibiotic binds to a pocket deep inside the RNAP clamp head domain, which interacts with the DNA template in the transcription bubble 5, 6 . Notably, binding of dMyx stabilizes refolding of the b9-subunit switch-2 segment, resulting in a configuration that might indirectly compromise binding to, or directly clash with, the melted template DNA strand. Consistently, footprinting data show that the antibiotic binding does not prevent nucleation of the promoter DNA melting but instead blocks its propagation towards the active site. Myxopyronins are thus, to our knowledge, a first structurally characterized class of antibiotics that target formation of the pre-catalytic transcription initiation complexthe decisive step in gene expression control. Notably, mutations designed in switch-2 mimic the dMyx effects on promoter complexes in the absence of antibiotic. Overall, our results indicate a plausible mechanism of the dMyx action and a stepwise pathway of open complex formation in which core enzyme mediates the final stage of DNA melting near the transcription start site, and that switch-2 might act as a molecular checkpoint for DNA loading in response to regulatory signals or antibiotics. The universally conserved switch-2 may have the same role in all multisubunit RNAPs.
Our data show that myxopyronins efficiently inhibit formation of transcription initiation complexes by both Escherichia coli and T. thermophilus RNAPs (Supplementary Fig. 1 ). The crystal structure of dMyx bound to the T. thermophilus RNAP holoenzyme (Fig. 1,  Supplementary Fig. 2 and Supplementary Table 1) has been refined at 2.7 Å resolution to the final R factor /R free 5 0.240/0.270. Comparison with the apo-RNAP (Protein Data Bank (PDB) accession 2A6E) showed a subtle but systematic dMyx-induced ,2.0-3.7 Å shift of the b9-subunit amino-terminal domain (residues b91-600) and the s-subunit in the RNAP-dMyx complex (Methods and Supplementary Fig. 3 ). This shift, however, did not change either the pattern of the s/core-RNAP interactions, or the arrangement of and the distance between the s-regions 2 and 4 which recognize the 210 and 235 promoter elements 5 . The configuration of the fork formed by the s-regions 2.3-2.4 and 2.5-3.1 at the upstream entrance to the RNAP main channel (where melting of the DNA duplex is thought to start [6] [7] [8] ) is also largely unaffected by dMyx. In the RNAP-dMyx complex, the width of the main channel is reduced by ,4 Å as compared to that in one of the two crystallographically independent molecules in the apo-RNAP. If systematic, this constriction could affect accommodation of the upstream DNA duplex and/ or DNA melting. However, the second apo-RNAP molecule also had the narrowed channel, indicating the inherent flexibility of the neighbouring domains and suggesting that the main channel width is unlikely to be a limiting factor for open complex formation ( Supplementary Fig. 4 ).
dMyx binds in the pocket deep inside the RNAP clamp head domain (Fig. 1a, b) , which constitutes the wall of the main channel opposite the catalytic centre and forms crucial contacts with the DNA template strand in the elongation complex 9, 10 . Although hydrophobic contacts probably have a dominant role in binding, most of the dMyx polar groups also form specific interactions with the protein (Fig. 1d and Supplementary Fig. 5 ). The most important and notable change observed in the presence of dMyx is refolding of the highly conserved b9 switch-2 segment (b9602-621; Fig. 1c) : the a-helix, interrupted in the middle by four flipped-out residues, is straightened, whereas its carboxy-terminal portion (,two-helical turns) unwinds and refolds into a loop (Fig. 1e, f) . This loop extends towards the active site, where it approaches the s hairpin loop 11 (s317-333; Fig. 1a, b) . To verify the dMyx-binding determinants revealed by the structure and to probe the role of switch-2 refolding in the dMyx mechanism, we performed in vitro mutational analysis of E. coli RNAP (Supplementary Information). As anticipated, substitutions of three residues (Ser b1322, Glu b1279 and Lys b9345, numbered as in E. coli; Fig. 1d ) making crucial interactions with dMyx conferred resistance to the antibiotic ( Fig. 2 and Supplementary Fig. 6 ). On the other hand, after the switch-2 refolding Lys 334 forms only weak van der Waals interactions with dMyx whereas Arg 337 and Arg 339 do not interact with the inhibitor at all (Fig. 1d) . Consistently, substitutions of these residues for Ala do not substantially affect inhibition by dMyx (Fig. 2) . To design switch-2 variants with altered refolding properties, we used the following considerations. First, we selected residues without essential direct contacts with dMyx. Second, deletion of two flipped-out residues, Lys 334 and Gln 335 (the integration of which into an a-helix probably initiates refolding; Fig. 1e ), would prevent both opening of the inhibitor-binding site and formation of the C-terminal loop. Third, in the structures without dMyx, Phe 338 is integrated into the hydrophobic core that probably stabilizes the original switch-2 conformation (Supplementary Fig. 7 ). The Phe/Ala substitution, as well as a deletion of 338-341 residues, would weaken these interactions, thereby presumably favouring refolding. Fourth, although in both conformations Gly 336 is located at the junction between the a-helical and unfolded portions, its main chain angles (w, y) appear in the disallowed and favourable (for the amino acids with side chains) regions of the Ramachadran plot for the original and refolded configurations, respectively, suggesting that its substitution for Ala would favour the refolded conformation. In support of structural considerations, the D334-335 was resistant, whereas the D338-341, F338A and G336A variants were hypersensitive to dMyx (Fig. 2) .
Switch-2 refolding may be pivotal for the dMyx action. Refolding opens the entry to the otherwise inaccessible dMyx-binding site ( Supplementary Fig. 8 ). Also, Arg b9610 and Gln b9611 are flipped out of the helix in the original switch-2 configuration and form hydrogen bonds with the DNA template in the elongation complex (and presumably in the initiation complex, where they may be crucial for stability of the transcription bubble) but lose these contacts on refolding (Fig. 1e, f) . This change may inhibit DNA melting beyond the register 23. Furthermore, the newly formed C-terminal loop would clash with the DNA template strand if melting propagates to register 11 ( Supplementary Fig. 9 ). This clash can hardly be avoided: although the upstream DNA (registers 22 to 210, and so on) may show relatively large deviations between the initiation and elongation complexes, the position of the acceptor template (i 1 1) is strongly restrained by base pairing with the incoming substrate and thus is probably identical in both states.
To complement the lack of structural information on the DNA conformation in the dMyx-inhibited complex, we tested this model using biochemical approaches. The model suggests that the properly positioned template strand would preclude refolding and thus Myx binding; indeed, dMyx failed to inhibit transcription if added to the preformed open promoter complex ( Supplementary Fig. 1b ). We then tested the effect of dMyx on RNAP-DNA contacts and the DNA strand separation in lP R promoter complexes using DNaseI and KMnO 4 footprinting, respectively. Consistent with published data [12] [13] [14] , the non-template strand thymidine residues at positions 24, 23 and 12 were hypersensitive to KMnO 4 modification in the absence of dMyx (Fig. 3a) . In the presence of inhibitor, the 12 position became strongly protected. DNaseI probing showed that dMyx induced a loss of protection (4-5 base pairs (bp)) at the downstream footprint boundary (on both DNA strands; Fig. 3a and data not shown). Similar patterns were observed in complexes trapped at intermediate steps of open complex formation 7, 14, 15 . Our structural data did not show any considerable antibioticdependent alterations of the RNAP structure that may affect DNA loading into the main channel at the upstream (210) promoter region. Consistently, our footprinting analysis demonstrates that dMyx does not prevent RNAP binding to promoter, nucleation of melting at approximately 211, or entry of the double-stranded downstream DNA into the enzyme. The antibiotic imposes a block to DNA melting only beyond register 23, in which the direct interactions with switch-2 are predicted by modelling (assuming that the DNA trajectory is not markedly changed between the initiation and elongation complexes). Moreover, dMyx inhibited transcription on the artificially melted promoters ( Supplementary Fig. 10) ; thus, it precludes the correct loading of the template DNA into the main channel even after complete strand separation. Overall, our present data favour a mechanism (Fig. 3b) in which local dMyx-stabilized refolding of switch-2 disrupts potentially critical interactions with and/or sterically occludes accommodation of the melted template DNA near the transcription start site, resulting in misplaced downstream DNA and inhibition of the strand separation. Further allosteric effects (for example, on the clamp opening/closing) of dMyx binding cannot be ruled out, but our study fails to demonstrate any indications of their importance in antibiotic action. A more detailed Our results, together with conformational transitions in switch-2 observed in eukaryotic RNAP 16, 17 , suggest that this region is inherently flexible and may influence the open complex formation in the absence of inhibitors. To test this hypothesis, we used KMnO 4 footprinting analysis of the lP R promoter complexes formed by switch-2 variants with altered refolding properties (Fig. 4) . In contrast to the wild-type RNAP, which formed a stable complex with the melted region extended to the 12 position, the two mutants lacking the Phe 338 side chain (that probably stabilizes the original switch-2 configuration) demonstrated prominent melting defects. The D338-341 enzyme alone behaves as the wild-type RNAP in the presence of dMyx: DNA melting at 12 is blocked, DNaseI footprint is shortened, and the complex is heparin sensitive (Supplementary Fig. 11 ). In F338A RNAP, the pattern of permanganate sensitivity is shifted further upstream: the 12 position is not melted and the 210 position becomes unprotected. Notably, addition of dMyx shifted all complexes into the same state (Fig. 4) . Taken together our data indicate that changes in the switch-2 designed to promote its refolding stabilize promoter intermediates in different states from the properly formed open complex, but are active on addition of substrates. Judging by the similarity of KMnO 4 footprints it is tempting to suggest that these states structurally resemble initiation intermediates of wild-type RNAP trapped by altering reaction conditions 7, 12, 14 . Although several arguments favour a hypothesis that the switch-2 state observed in the presence of dMyx resembles a 'physiological' (dMyx-independent) intermediate as opposed to an antibioticinduced dead-end complex (Supplementary Information), we cannot definitively prove this notion. Thus, the detailed understanding of the effects of the substitutions used in this work requires further structural and biochemical characterization. However, our present findings support a mechanism of open complex formation that involves sequential bending of the promoter DNA upstream and downstream of the RNAP main channel as the pivotal transitions. The upstream bend is thought to originate from the s-subunit-DNA contacts and induces upstream DNA melting ,60 Å away from the catalytic centre 7, 11, 13 . In contrast, the subsequent step is probably s-independent and is set near the active site, in which interactions of DNA with the core enzyme (11) is shown by a black dot. The top panel shows probing of the nontemplate strand by piperidine-induced cleavage of the permanganatemodified T residues. Reactivities of 210, 24, 23 and 12 residues (quantification described in Methods) are shown to the left of the gel and summarized above the promoter sequence where black and white arrows indicate high and low reactivity, respectively. The bottom panel shows protection of the non-template DNA strand from DNaseI digestion. The footprint boundaries in the promoter region shown are indicated on the gel and by black (RNAP alone) and white (RNAP with the inhibitor) bars below the promoter sequence; the dideoxy-sequencing ladder is shown for reference. In the gels shown, independent reaction repeats were analysed for consistency. b, Schematic drawing of the putative mechanism of the dMyx action. dwDNA, downstream DNA. introduce a sharp kink in the template strand 9,10 that may facilitate opening of the DNA duplex at the downstream edge, thereby finalizing the opening of the transcription bubble. Although the mechanisms of initiation of DNA melting are vastly different between bacterial and eukaryotic enzymes, the final (core-mediated) step of the DNA melting and the template strand loading into the active site is presumably fundamentally conserved, to give rise to essentially identical 'final' states observed in the structures of the active transcription complexes.
METHODS SUMMARY
dMyx was synthesized as described previously 4 . Crystallization of the complex was carried out under essentially the same conditions as for the apo-RNAP holoenzyme 18 . The structure was refined to a final R factor /R free of 0.240/0.270 at 2.7 Å resolution ( Supplementary Fig. 2 and Supplementary Table 1) . Escherichia coli rpoB and rpoC mutant vectors were constructed by side-directed mutagenesis and purified as described previously 18 . Footprinting analysis was performed using standard protocols 6, 12 . See Methods for detailed experimental procedures. Accessibility of the non-template DNA strand residues to permanganate modification probed as in Fig. 3a . Wild-type and mutant RNAPs differ in their patterns of reactivity in the absence of dMyx (top traces) but are nearly identical in the presence of 10 mM dMyx (bottom traces). Notably, b9D309-325 that removes the entire rudder loop (which is inserted in the same helix as switch-2, but is unlikely to interfere with the nucleic acids) has no effect on DNA melting, suggesting that a melting defect of a different rudder deletion 19 might be due to changes in the adjacent switch-2 instead.
METHODS
Structure determination and refinement. The T. thermophilus RNAP holoenzyme was purified and crystallized as described previously 20 . To obtain the complex crystals, the crystals of the apo-holoenzyme were transferred for 3 h into the drops containing collection buffer and 2 mM of dMyx 4 . The data were collected at beam line GM/CA-CAT (Advanced Photon Source, Argonne, USA). The crystals, although belonging to the same space group P3 2 , had distinct unit cell parameters, a 5 b 5 235 Å , c 5 255 Å , as compared to the two previously studied T. thermophilus RNAP crystal forms; form I (a 5 b 5 236 Å , c 5 250 Å ) [20] [21] [22] and form II (a 5 b 5 240 Å , c 5 253 Å ) [23] [24] [25] . The data were processed using the HKL2000 data processing package (Supplementary Table 1) 26 . As for all previous holo-RNAP crystals, the crystals of the RNAP-dMyx complex were characterized by the perfect merohedral twinning coupled with the non-crystallographic symmetry 20 . Refinement, therefore, was carried out using the twinning option of the CNS program (Supplementary Table 1) 27 . The RNAP structure from the RNAPTgt complex (PDB accession 2BE5), from which the bridge helix (b91067-1104) and the switch-2 segment (b9602-621) were omitted, was used as a starting model. Zonal scaling correction 10 substantially improved the initial R free and the quality of the electron density. The j2F obs 2 F calc j electron density map calculated after the rigid body and B-factor refinement steps revealed the undistorted bridge helix (characteristic of the crystal form II, see earlier), straightening of the switch-2 a-helix and a very clear electron density for dMyx. However, the unfolded C-terminal portion of the switch-2 (residues b9613-619) structure was represented by a fragmentary electron density that allowed for alternative interpretations. After several trials, using the reduced level of the electron density (,0.8s, which was still above the noise) we were able to build a proper model that was characterized by a good, continuous electron density in the j2F obs 2 F calc j electron density map for both the side-and main-chain atoms (note that all the previous partially wrong models did not improve the quality of the electron density in this region). After modelling of dMyx and switch-2 structures in the omit electron density, several rounds of the B-factor, positional, simulated annealing refinements and water 'pick' and water 'delete' procedures, alternating by manual model building using the program O 28 yielded a final R factor of 24.0% and R free of 27.0% for the RNAP-dMyx complex at 2.7 Å resolution (Supplementary Table 1 ). The final model was of high quality as shown by the simulated annealing omit electron density map calculated for dMyx and the switch-2 motif (Supplementary Fig. 1 ). Structural figures were prepared using programs Molscript 29 , Bobscript 30 and Raster3D 31 . Isolation and assay of mutant E. coli RNAPs. Core wild-type and mutationally altered RNAPs were purified as described previously 18 except that the ionic strength was maintained at or above 0.2 M at all chromatographic steps. Overexpression plasmids for b9 R339A (pIA830), b E1279A (pIA870), b S1322E (pIA878), b9 G336A (pIA880), b9 F338A (pIA881), b9 K345A (pIA882), b9 D334-335 (pIA883), b9 K334A (pIA879), b9 D338-341 (pIA890) and b9 R337A (pGB055) were constructed by site-directed mutagenesis and the sequenced fragments were recloned into pVS10-based vectors 18 . Holoenzymes were reconstituted with the twofold molar excess of s
70
. For steady-state abortive initiation assays, holo RNAP (20 nM) in 16 ml of 20 mM Tris-acetate, 20 mM sodium acetate, 2 mM magnesium acetate, 5% glycerol, 1 mM dithiothreitol (DTT), 0.1 mM EDTA, pH 7.9, 1 mM s 70
